The Use of AlloDerm in Postmastectomy Alloplastic Breast Reconstruction: Part II. A Cost Analysis

Jansen, Leigh A.; Macadam, Sheina A.

doi:10.1097/prs.0b013e3182131c6b

Cited by 93 publications

(46 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although acellular dermal matrix-assisted reconstruction addresses some of the difficulties encountered with direct-to-implant reconstruction, it may Plastic and Reconstructive Surgery • December 2015 increase wound complication risks and represents a considerable source of health care costs. 39,[48][49][50] Finally, management of patient expectations and satisfaction is particularly concerning in singlestage reconstruction. Indeed, the basis for choosing direct-to-implant reconstruction is to obtain a breast mound immediately and avoid a second operation at the same time.…”

Section: Patient Selectionmentioning

confidence: 99%

A Systematic Review and Head-to-Head Meta-Analysis of Outcomes following Direct-to-Implant versus Conventional Two-Stage Implant Reconstruction

Basta

Gerety

Serletti

et al. 2015

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

Although direct-to-implant and two-stage tissue expander/implant reconstruction are successful approaches, this meta-analysis demonstrates significantly greater risk of flap necrosis and implant failure with direct-to-implant reconstruction. The authors' findings suggest that the critical component of patient selection is judgment of mastectomy flap tissue quality. These findings can enhance the risk counseling process and highlight the need for additional investigations to optimize outcomes.

show abstract

Section: Patient Selectionmentioning

confidence: 99%

A Systematic Review and Head-to-Head Meta-Analysis of Outcomes following Direct-to-Implant versus Conventional Two-Stage Implant Reconstruction

Basta

Gerety

Serletti

et al. 2015

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…Major series have been published, although none exhibits greater than Level III evidence (Table 2), and proponents appear to be on both sides of this discussion, making definitive conclusions impossible at this stage. 26,27,[30][31][32]35 …”

Section: Breastmentioning

confidence: 99%

Regenerative Biomaterials

Banyard

Bourgeois

Widgerow

et al. 2015

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

The authors present a review of biomaterials, substances traditionally derived from human or animal tissue or, more recently, biodegradable synthetics modeled after naturally occurring resources. These constructs differ from purely synthetic materials in that they are degraded or incorporated into a host's tissue. These biomaterials include a diverse array of medical products, such as acellular dermal matrix, bone substitutes, and injectables. In this review, the authors examine various clinical applications, including burn reconstruction and wound healing, breast surgery, complex abdominal wall reconstruction, craniofacial repair, and cosmetic surgery. Biomaterials such as acellular dermal matrix have proven beneficial in difficult-to-treat applications; however, more prospective data are needed to determine their true efficacy and cost-effectiveness.

show abstract

“…The cost of materials for breast reconstructionincluding tissue expander, breast prosthesis, and collagen regenerative tissue matrix-were obtained from a cost analysis conducted in British Columbia 18 . To calculate the mean professional and materials costs of breast FIGURE 1 Decision tree for the cost model.…”

Section: Methodsmentioning

confidence: 99%